These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 9642078
1. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. Rahuel J, García-Echeverría C, Furet P, Strauss A, Caravatti G, Fretz H, Schoepfer J, Gay B. J Mol Biol; 1998 Jun 19; 279(4):1013-22. PubMed ID: 9642078 [Abstract] [Full Text] [Related]
2. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A. J Mol Biol; 2002 Feb 01; 315(5):1167-77. PubMed ID: 11827484 [Abstract] [Full Text] [Related]
3. Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain. Furet P, Gay B, García-Echeverría C, Rahuel J, Fretz H, Schoepfer J, Caravatti G. J Med Chem; 1997 Oct 24; 40(22):3551-6. PubMed ID: 9357522 [Abstract] [Full Text] [Related]
13. Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1). Ettmayer P, France D, Gounarides J, Jarosinski M, Martin MS, Rondeau JM, Sabio M, Topiol S, Weidmann B, Zurini M, Bair KW. J Med Chem; 1999 Mar 25; 42(6):971-80. PubMed ID: 10090780 [Abstract] [Full Text] [Related]
14. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems. Wei CQ, Gao Y, Lee K, Guo R, Li B, Zhang M, Yang D, Burke TR. J Med Chem; 2003 Jan 16; 46(2):244-54. PubMed ID: 12519063 [Abstract] [Full Text] [Related]
15. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. Yao ZJ, King CR, Cao T, Kelley J, Milne GW, Voigt JH, Burke TR. J Med Chem; 1999 Jan 14; 42(1):25-35. PubMed ID: 9888830 [Abstract] [Full Text] [Related]
16. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S. MacLean D, Sefler AM, Zhu G, Decker SJ, Saltiel AR, Singh J, McNamara D, Dobrusin EM, Sawyer TK. Protein Sci; 1995 Jan 14; 4(1):13-20. PubMed ID: 7773170 [Abstract] [Full Text] [Related]
17. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin. Shi YH, Song YL, Lin DH, Tan J, Roller PP, Li Q, Long YQ, Song GQ. Biochem Biophys Res Commun; 2005 May 20; 330(4):1254-61. PubMed ID: 15823578 [Abstract] [Full Text] [Related]
18. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide. Ahn SC, Oh WK, Kim BY, Kang DO, Kim MS, Heo GY, Ahn JS. Planta Med; 2003 Jul 20; 69(7):642-6. PubMed ID: 12898421 [Abstract] [Full Text] [Related]
20. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution. Tong L, Warren TC, King J, Betageri R, Rose J, Jakes S. J Mol Biol; 1996 Mar 01; 256(3):601-10. PubMed ID: 8604142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]